PDA is not separately listed no FDA guidance, ruling, or bulks entry mentions "pentadeca arginate." However, PDA meets none of the three criteria required for legal 503A compounding: no USP monograph, not a component of any FDA-approved drug, and not on the Category 1 bulks list
Veyong has two production bases: Shijiazhuang and Ordos, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects
THEY ARE NOT IN A STERILE SOLUTION OR FOR INJECTION
Talk to your doctor about what your specific results mean
Even with the coming AP article and request for comment the game of whack a mole continues and a number of these banned peptides remained available on both platforms